Cite

HARVARD Citation

    Potjewyd, F. et al. (2022). Use of AD Informer Set compounds to explore validity of novel targets in Alzheimer's disease pathology. Alzheimer's & dementia. 8 (1), p. n/a. [Online]. 
  
Back to record